Head-to-head · Cost-Efficiency Index
AHBARx vs Fitish
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
AHBARx
Shoppers who want one number that already contains the visit fee and the shipping, and who will read the terms before subscribing.
Visit AHBARxFitish
Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option.
Visit FitishThe verdict
AHBARx takes it, leading the Cost-Efficiency Index 70 to 69. AHBARx sells compounded semaglutide at $249 and tirzepatide at $349 a month with the consultation and shipping folded into the figure, and shows both prices at checkout before you make an account. Fitish still earns a C — Shoppers who want a genuinely all-in price with no separate consult fee, or a fixed low-dose 'microdose' option.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs AHBARx.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | AHBARx | Fitish |
|---|---|---|
| Cost-Efficiency Index | 70/100 | 69/100 |
| Semaglutide / mo | $249/mo month-to-month (a $50 consultation and $25 shipping are inside the figure) | $219/mo (microdose tier, plus a separate fee, compounded) |
| Tirzepatide / mo | $349/mo month-to-month (consultation and shipping included in the figure) | $339/mo (microdose tier, compounded) |
| Semaglutide / yr (modeled) | $2,988 | $2,628 |
| Tirzepatide / yr (modeled) | $4,188 | $4,068 |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank here | #89 | #92 |
AHBARx
70/100Where the value is
- Both monthly prices, the $50 consultation and the $25 shipping are itemized on a checkout panel you can reach without an account or an intake
- Names its compounding partner, AnazaoHealth, and its clinical partners, Beluga Health and Qualiphy
- Names a founding physician with credentials on the About page rather than referring only to a network
The tradeoffs
- The terms of service and the privacy policy are unedited templates: they still print "[list of Pharmacies]", "[list of Labs]", "[phone number]" and even "[www.ahbarx.com]" where the company's own details belong
- The About page says there are no membership fees while the terms require "the Weight Loss Membership on an automatically renewing monthly subscription basis" — no membership line appears at checkout, so which one governs is unclear
Fitish
69/100Where the value is
- Price genuinely includes consult, medication, and shipping — confirmed in the product page's own text, not just marketing copy
- A real microdose tier exists at a meaningfully lower fixed price for both drugs
- Injectable and oral tablet formats both offered
The tradeoffs
- No stated minimum commitment or cancellation terms found on the product pages
- No named prescriber, medical director, or specific compounding pharmacy
Regulatory note: the FDA issued a warning letter to FITISH in June 2026. We still list and link to Fitish; you should know the letter is on the public record before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.